Yoneda et al. [24] reported the PD-L1 expression of 41 patients with stage II-III NSCLC who underwent neoadjuvant chemoradiation (n = 23) or chemotherapy (n = 18) before surgical resection. The gene discussed is CD274; the disease is non-small cell lung carcinoma.